848217-05-0

Upstream product

• 141-43-5 ethanolamine 
• 443667-38-7 5-benzoyl-6-(bromomethyl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione 
• 13509-52-9 1,3,6-trimethyluracil 
• 444058-30-4 5-benzoyl-1,3,6-trimethylpyrimidine-2,4(1H,3H)-dione 

Downstream Products

• 1613622-40-4 1,3-dimethyl-10-(5-methylfuran-2-yl)-5-phenyl-7,8-dihydro-1H-pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]oxazine-2,4(3H,10H)-dione 
• 1613623-38-3 2-(2-(1,3-dimethyl-2,4-dioxo-5-phenyl-3,4-dihydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)ethoxy)-N-methoxy-N-methylacetamide 
• 1613623-39-4 6-(2-(2-(4-chlorothiazol-2-yl)-2-oxoethoxy)ethyl)-1,3-dimethyl-5-phenyl-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione 
• 1613623-40-7 6-(2-(2-(4-chlorothiazol-2-yl)-2-hydroxyethoxy)ethyl)-1,3-dimethyl-5-phenyl-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione 
• 1613623-41-8 11-(4-chlorothiazol-2-yl)-1,3-dimethyl-5-phenyl-7,8,10,11-tetrahydropyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazepine-2,4(1H,3H)-dione 
• 1613623-36-1 (S)-11-(4-chlorothiazol-2-yl)-1,3-dimethyl-5-phenyl-7,8,10,11-tetrahydropyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazepine-2,4(1H,3H)-dione 
• 1613623-37-2 (R)-11-(4-chlorothiazol-2-yl)-1,3-dimethyl-5-phenyl-7,8,10,11-tetrahydropyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazepine-2,4(1H,3H)-dione 

Relevant academic research and scientific papers

TRICYCLIC COMPOUNDS

The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.